mHealth Intervention to Promote Cancer Survivors' Physical Activity
Completed · Not applicable
Conditions studied: Physical Activity, Quality of Life
In brief
The Primary Goal is to conduct a 5-10 week randomized controlled trial (RCT) of the Fitbit Flex, a popular, affordable, wearable physical activity tracking device, and the Fitbit mHealth app. The target population will be childhood cancer survivors 14-18 years old recruited from Seattle Children's Hospital. For the intervention group, peer influences will be engaged via a private, social network (e.g. a Facebook group) customized for survivors. Measurements will be completed (1) at baseline, prior to randomization, and (2) during the final week of the intervention period (follow-up measure). This study will provide initial proof of concept and allow for further customization of the intervention for childhood cancer survivors in anticipation of a future, larger proposal to study physical activity and related outcomes over a multi-year period.
Key facts
- Study ID
- NCT02469727
- Run by
- Seattle Children's Hospital
- People needed
- 60
- Starts
- 2015-07-01
- Expected to finish
- 2016-07-01
- Last updated by the study team
- 2016-10-13
Who can join
Age: 14 and older, up to 18. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- in remission for childhood cancer and previously treated for childhood cancer at Seattle Children's Hospital
- ≥1-year post-cancer therapy
- ambulatory without any known medical contraindications to participation
- able to complete surveys in English
- agree to install and share data from the FitBit smart phone app with the investigators
You may not qualify if…
- currently or previously used a wearable physical activity sensing device to improve physical activity
Where it is running
- Seattle Children's Research Institute — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.